TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Measurement of antibody levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Measurement of cellular immune responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Expression of microbial and viral DNA/RNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in Beryllium Lymphocyte Proliferation Responses (BeLPT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Graft dislocation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in Pulsatility index (PI) of the middle cerebral artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Resistance index (RI) of the middle cerebral artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in C-peptide Area Under the Curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: EMG activity of upper trapezius, lower trapezius and serratus anterior
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Examiner Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hoarding Rating Scale Interview
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinician's Global Impression Improvement and Severity ratings
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of gastric outlet obstruction recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Performance at the SET (Six Elements Test)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of surgical staging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Free-living daily energy expenditure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in Severity of MR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anterior chamber cells greater than level 1+ persisting at Visit 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hypotony (≤ 5 mmHg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline Visual Analogue Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline Roland 5-point pain scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline Patient satisfaction scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fruit intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nutritional outcomes
Primary endpoint: Vegetable intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nutritional outcomes
Primary endpoint: Total exposure (AUC(0 to infinity)) of GSK2212836
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak exposure (Cmax) of GSK2212836
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative bioavailability of GSK2212836 test capsules vs reference formulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of recruited participants
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percent Excess Weight Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Achieving Objective Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ratio of positivity conversion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Opening Minds Scale for Health Care Providers (OMS-HC)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mental Illness: Clinicians Attitudes Scale (MICA)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Modified Borgadus Social Distance Scale
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Diagnostic performance of LUS to predict poor outcome
Endpoint domain: Mortality/survival
Primary endpoint: Lower limb strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6-month confirmed disability progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vascular elasticity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Severe infection rate
Endpoint domain: Adverse events/effects
Primary endpoint: hematology
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Time in Days From Diagnosis to Stone Passage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Circulating micro RNA concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kinematic metrics change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with normalized 24-hour urinary free cortisol (UFC) at study completion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Number of participants with UFC above the upper limit of normal (ULN) but reduced by ≥50% from baseline at study completion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change from baseline in seated systolic blood pressure at trough
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from baseline in urine albumine excretion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change from baseline in pulse wave velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Major-Adverse Cardiac or Cerebral Events
Endpoint domain: Adverse events/effects
Primary endpoint: Anatomy accuracy - LAA size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anatomy accuracy - LA size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary lithogenic factors variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Concentration of serum C-peptide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: success in providing surgical anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Time to Estradiol > 35 pg/ml
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Amount of pain reducing medication used
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Baro-reflex sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Occurrence of Adverse events related to hepatic function
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of Adverse events related to renal function
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of Adverse events related to Ophthalmological function
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of Adverse events related to hematological function
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of Adverse events related to cognitive developmental function
Endpoint domain: Adverse events/effects
Primary endpoint: Gene Expression Changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of patients fear of having a bleeding
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Level of patients fear of having a stroke or thrombosis
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Visual Pain Assessment Scale for procedural pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Pain Assessment Scale for postoperative pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants That Did Not Develop Inhibitors to FVIII
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients with local failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Severity of obstructive sleep apnea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: Clinician-rated Liebowitz Social Phobia Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Social Phobia Inventory
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Child mental health
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Total ADHD Symptoms score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analogue Scale (VAS) in Resting Stage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak plasma concentrations (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Protection of the lower airways
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Safety of FCD
Endpoint domain: Adverse events/effects
Primary endpoint: Performance of FCD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of Intact Parathyroid Hormone (iPTH) Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in the Alzheimer's Disease Assessment Scale-Cognitive (ADAS-Cog)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Abnormal cardiac magnetic resonance imaging (CMRI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Prevalence of dosage above guidelines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in total body water
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in number of drinks in a typical week
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Tumor Overall Response Rates (ORRs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Insulin integrated area under the curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: pharmacokinetics of simvastatin, caffeine, omeprazole, and diclofenac
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: activity monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: implant migration and wear
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Early pregnancy loss
Endpoint domain: Mortality/survival
Primary endpoint: serum neutrophil-count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS (visual analog score)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: morphine consumption (mg)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of Root Coverage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum T Cell Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Patients' views on induction of labour, prior to induction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patients' views on induction of labour, post induction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinicians' views on various induction protocols
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patients' views on the fetal monitoring regimens during the induction process
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Staff's views on the fetal monitoring regimens during the induction process
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement based on a composite of systemic and local features
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pulse oximeter positivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Childbirth Perception Questionnaire (CPQ) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in PTSD Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Who Were ADHD Respondents
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of Participants Who Were Autism Spectrum Disorder Respondents
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: microbiological counts on skin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Prevalence of dysplastic lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Neck Pain and Disability Scale (NPDS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Duration of remission
Endpoint domain: Mortality/survival
Primary endpoint: Improvement in atopic eczema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Incidence of lingual nerve injury
Endpoint domain: Adverse events/effects
Primary endpoint: Area under the time-concentration curve for serum concentrations of peginterferon beta-1a
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transplant success
Endpoint domain: Mortality/survival
Primary endpoint: success of spinal anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Validation of a Predictive Score of Acute Chest Syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Opiate withdrawal symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Opiate agonist symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative duration of apnea-bradycardia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Per-Vessel Sensitivity of CTP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Per-Vessel Specificity of CTP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Shear Wave Speed within the thrombus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful restoration of bile duct drainage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Rate of all death
Endpoint domain: Mortality/survival
Primary endpoint: Rate of all stroke
Endpoint domain: Mortality/survival
Primary endpoint: Number of Participants With the Indicated Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Activities of Daily Living
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: absence of liver or muscle-related toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: IPSS urinary symptomatology score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Worst Pain
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Average Pain
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Interference
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Composite Success Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MAE (Major Adverse Event)
Endpoint domain: Adverse events/effects
Primary endpoint: major hematologic improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Button Press Reaction Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Button Press Accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proactive EEG Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reactive EEG Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retention in the study
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Retention in psychosocial treatment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Time to Asthma Exacerbation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in number of endothelial progenitor cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in number of micro vesicles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of patients with ablated HCC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: maximum tolerated doses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: falls avoidance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: metabolic consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: incidence of all serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of spina bifida
Endpoint domain: Mortality/survival
Primary endpoint: haemagglutination inhibition (HAI) responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: days of fever
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: days of antibiotics therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Morphine Requirements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physiologic signals
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent BOLD signal change in cognitive control network
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Progression-free Survival (PFS) Greater Than or Equal to 12 Weeks
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of clinically significant changes in laboratory tests, ECGs, and vital signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants with confirmed EDSS improvement at 12 months
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Functional assessment by Fried Criteria
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Fall Risk by test up and go
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The Lawton Instrumental Activities of Daily Living (IADL) Scale
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Barthel Test for dependency
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Difference in number of unprotected acts of anal intercourse
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Lung parenchymal tissue density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Alpha EEG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Rate of Induction To Delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average Electrical Impedance on the End-Expiration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Serum AMH level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Reduction in pain domain score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of Participants Whose Anti-HEV Antibody Seroconverted
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Geometric Mean Concentrations of Anti-HEV Antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Outcomes of geriatric trauma patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric mean titres of MenC specific serum bactericidal antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Response rate to PF-06463922
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Serum Autoantibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Systemic Lupus Erythematosus Disease Activity Index (SLEDAI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative uncorrected visual acuity (UCVA) at week 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative best spectacle corrected visual acuity (BSCVA) at week 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative uncorrected visual acuity (UCVA) at month 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wake After Sleep Onset
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: Sleep Onset Latency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: Sleep Efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep